Traditional Chinese medicine preparation for treating chronic heart failure and preparation method thereof

Abstract

The invention belongs to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine preparation for treating chronic heart failure and a preparation method of the traditional Chinese medicine preparation. The traditional Chinese medicine preparation is characterized by being prepared from the following traditional Chinese medicine raw materials in parts by weight: 10-15 parts of pseudo-ginseng, 15-20 parts of radix salviae miltiorrhizae, 10-15 parts of prepared rehmannia roots, 3-5 parts of desertliving cistanche, 3-5 parts of cyperus rotundus linn, 3-5 parts of asiatic cornelian cherry fruits, 1-2 parts of Chinese wolfberry, 2-3 parts of fossil fragments, 10-15 parts of bluish dogbane, 3-5 parts of cortex moutan, 5-8 parts of ligusticum wallichii, 5-10 parts of motherwort and 2-3 parts of common curculigo rhizomes. The traditional Chinese medicine preparation disclosed by the invention has the advantages that the used traditional Chinese medicines conform to the regulations of the pharmacopoeia of the people's republic of China, and the medicines are safe and reliable. All the medicines are matched to have the efficacies of benefiting heart qi, promoting blood circulation for removing blood stasis, promoting diuresis, resolving phlegm and the like, and the traditional Chinese medicine preparation has the characteristics of precise curative effect, fast effect, high cure rate, zero side effect and the like when being used for treating the chronic heart failure.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine preparation for treating chronic heart failure and a preparation method thereof. Background technique [0002] Chronic heart failure (CHF) is a clinical syndrome in the severe or terminal stage of various cardiac diseases. The common causes of CHF are coronary heart disease, hypertension, diabetes and various cardiomyopathy, among which heart failure caused by coronary heart disease is the first. [0003] The morbidity and mortality of CHF remain high, which is closely related to the clinical course of CHF. The 2007 Chinese Guidelines for the Diagnosis and Treatment of Chronic Heart Failure and the 2005 American Heart Failure Guidelines both pointed out that CHF is a progressive disease. Once it starts, even if there is no new myocardial damage, it is still in a stable clinical stage and can still continue on its own. devel...

AI Technical Summary

Problems solved by technology

[0008] Traditional drugs for the treatment of CHF mainly include diuretics, ACEI (angiotensin-converting enzyme inhibitors), vasodilators, cardiotonic agents, myocardial nutrients, calcium channel blockers, etc., but they have not fundamentally improved the quality of life of patients , also failed to effectively reduce the mortality rate of CHF, and there are many problems in clinical application